2-carboxyethyl gamma-aminobutyric acid: has growth effect on hybridomas; found in mammalian brain [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 2572 |
| CHEBI ID | 138529 |
| SCHEMBL ID | 7389117 |
| MeSH ID | M0130551 |
| Synonym |
|---|
| 4-[(2-carboxyethyl)amino]butanoic acid |
| 4-((2-carboxyethyl)amino)butyric acid |
| einecs 224-497-0 |
| 2-carboxyethyl gamma-aminobutyric acid |
| brn 1774240 |
| spermidic acid |
| butanoic acid, 4-((2-carboxyethyl)amino)- |
| 4-((2-carboxyethyl)amino)butanoic acid |
| carboxyethyl-gamma-aminobutyric acid, hybri-max(tm), powder, gamma-irradiated, bioxtra, suitable for hybridoma |
| carboxyethyl-gamma-aminobutyric acid, >=80% (hplc) |
| CHEBI:138529 |
| 4386-03-2 |
| FT-0694688 |
| 4-(2-carboxyethylamino)butanoic acid |
| AKOS005257194 |
| 4-04-00-02609 (beilstein handbook reference) |
| vo6u3596jp , |
| unii-vo6u3596jp |
| butyric acid, 4-((2-carboxyethyl)amino)- |
| cegaba |
| n-(2-carboxyethyl)-4-amino-n-butyric acid |
| carboxyethyl aminobutyric acid |
| .beta.-alanine, n-(3-carboxypropyl)- |
| butyric acid, 4-((2-carboxyethyl)amino) |
| carboxyethyl aminobutyric acid [inci] |
| SCHEMBL7389117 |
| n-carboxyethyl-.gamma.-aminobutyric acid |
| butanoic acid, 4-[(2-carboxyethyl)amino]- |
| SRGQUICKDUQCKO-UHFFFAOYSA-N |
| 4-(2-carboxy-ethylamino)-butyric acid |
| n-carboxyethyl-g-aminobutyric acid |
| DTXSID80195963 |
| spermidate |
| carboxyethyl-gaba |
| n-carboxyethyl-gamma-aminobutyric acid |
| n-carboxyethyl-gamma-aminobutyrate |
| 4-(2-carboxy-ethylamino)-butyrate |
| n-(2-carboxyethyl)-4-aminobutyric acid |
| 4-(2-carboxyethylamino)butyric acid |
| Q27291928 |
| 4-((2-carboxyethyl)amino)butanoicacid |
| carboxyethyl- gamma -aminobutyric acid |
| AT37423 |
| mfcd00057954 |
| Class | Description |
|---|---|
| organonitrogen compound | Any heteroorganic entity containing at least one carbon-nitrogen bond. |
| organooxygen compound | An organochalcogen compound containing at least one carbon-oxygen bond. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||